Open access
Open access
Powered by Google Translator Translator

Study suggests there is little added value from follow-up pelvic CT after treatment of hepatocellular carcinoma

23 Feb, 2023 | 13:39h | UTC

Summary: The study investigated the added value of pelvic coverage at follow-up liver CT in detecting pelvic metastasis or incidental tumors in patients treated for hepatocellular carcinoma (HCC). The study found that the incidence of isolated pelvic metastasis or incidental pelvic tumor was low in patients treated for HCC. The cumulative rates of isolated pelvic metastasis and incidental pelvic tumor were 1.4% and 0.5%, respectively, at 3 years. Only baseline T stage was associated with an increased risk of isolated pelvic metastasis. The study concludes that excluding the pelvic scan can reduce radiation dose and decrease the workload for radiologists. However, the study also had limitations, such as being retrospective and single-center. Therefore, more research is necessary to study the optimal scanning strategy for the pelvis and the effect of pelvic CT coverage on survival in patients with HCC.

Article: Added Value of Pelvic CT after Treatment of HCC – Radiology

Commentary: Is Follow-Up Pelvic CT Coverage Necessary for Patients Treated for Hepatocellular Carcinoma? – Diagnostic Imaging


Stay Updated in Your Specialty

Telegram Channels

WhatsApp alerts 10-day free trial

No spam, just news.